Market Overview:
The global antihypertensive drugs market is expected to exhibiting a CAGR of XX% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Antihypertensive drugs are therapeutic medications used for preventing, controlling and treating hypertension and high blood pressure disorders. Hypertension is the prolonged and persistent elevation in blood pressure, which can lead to cardiac stroke and aneurism. Some commonly used antihypertensive drugs include diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors and vasodilators. These drugs remove excess fluids and salts from the body and relax and widen the blood vessels. They also aid in slowing down the heartbeat and maintaining a healthy systolic blood pressure. These drugs can be administered orally or through intravenous injections and are widely used in hospitals, clinics, rehabilitation centers and ambulatory surgical centers.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Antihypertensive Drugs Market Trends:
The increasing prevalence of hypertension and cardiovascular disorders across the globe is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is anticipated to drive the market toward growth. Due to the increasingly sedentary lifestyles and adoption of unhealthy dietary patterns, there is an alarming increase in the number of patients suffering from high blood pressure and hypertension. This has led to the widespread adoption of antihypertensive drugs for timely prevention and treatment of hypertension. In line with this, the widespread adoption of combination therapies is contributing to the growth of the market. These innovative therapies combine multiple drugs to treat several hypertensive mechanisms, resulting in reduced occurrence of cerebrovascular events and coronary issues. Additionally, the development of imidazolines, monatepil and neutral endopeptidase inhibitors are acting as other growth-inducing factors. These next-generation drugs cause minimal fatigue and dry mouth and can also aid in lowering blood pressure by inhibiting the metabolism of vasoactive peptides. Other factors, including rising healthcare expenditures of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global antihypertensive drugs market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapeutic class, type and distribution channel.
Breakup by Therapeutic Class:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
Breakup by Type:
- Primary Hypertension
- Secondary Hypertension
Breakup by Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- E-Commerce
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries Ltd.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Therapeutic Class, Type, Distribution Channel, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
AstraZeneca, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries Ltd. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global antihypertensive drugs market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global antihypertensive drugs market?
- What are the key regional markets?
- What is the breakup of the market based on the therapeutic class?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global antihypertensive drugs market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Antihypertensive Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Therapeutic Class
6.1 Diuretics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 ACE Inhibitors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Calcium Channel Blockers
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Beta-adrenergic Blockers
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Vasodilators
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Type
7.1 Primary Hypertension
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Secondary Hypertension
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Retail Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospital Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 E-Commerce
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AstraZeneca
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Boehringer Ingelheim International GmbH
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Daiichi Sankyo Company Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Johnson & Johnson Services Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Lupin Pharmaceuticals Inc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sun Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Antihypertensive Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antihypertensive Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Antihypertensive Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Antihypertensive Drugs Market: Breakup by Therapeutic Class (in %), 2021
Figure 5: Global: Antihypertensive Drugs Market: Breakup by Type (in %), 2021
Figure 6: Global: Antihypertensive Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Antihypertensive Drugs Market: Breakup by Region (in %), 2021
Figure 8: Global: Antihypertensive Drugs (Diuretics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Antihypertensive Drugs (Diuretics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Antihypertensive Drugs (ACE Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Antihypertensive Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Antihypertensive Drugs (Vasodilators) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Antihypertensive Drugs (Vasodilators) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Antihypertensive Drugs (Primary Hypertension) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Antihypertensive Drugs (Primary Hypertension) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Antihypertensive Drugs (Secondary Hypertension) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Antihypertensive Drugs (Secondary Hypertension) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Antihypertensive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Antihypertensive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Antihypertensive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Antihypertensive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Antihypertensive Drugs (E-Commerce) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Antihypertensive Drugs (E-Commerce) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Antihypertensive Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Antihypertensive Drugs Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Antihypertensive Drugs Industry: SWOT Analysis
Figure 80: Global: Antihypertensive Drugs Industry: Value Chain Analysis
Figure 81: Global: Antihypertensive Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Antihypertensive Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Antihypertensive Drugs Market Forecast: Breakup by Therapeutic Class (in Million US$), 2022-2027
Table 3: Global: Antihypertensive Drugs Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 4: Global: Antihypertensive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Antihypertensive Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Antihypertensive Drugs Market: Competitive Structure
Table 7: Global: Antihypertensive Drugs Market: Key Players